Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer.
Marta PalafoxLaia MonserratMeritxell BelletGuillermo VillacampaNuria Lopez-BigasMafalda OliveiraFara Brasó-MaristanyNusaibah IbrahimiSrinivasaraghavan KannanLeonardo MinaMaria Teresa Herrera-AbreuAndreu ÒdenaMònica Sánchez-GuixéMarta CapelánAnalía AzaroAlejandra BrunaOlga RodríguezMarta GuzmánJudit GruesoCristina ViaplanaJavier Hernández-LosaFaye SuKui LinRobert B ClarkeCarlos CaldasJoaquín ArribasStefan MichielsAlicia García-SanzNicholas C TurnerAleix PratPaolo G NuciforoRodrigo DienstmannChandra S VermaNúria López-BigasMaurizio ScaltritiMonica ArnedosCristina SauraVioleta SerraPublished in: Nature communications (2022)